Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06710847 |
Title | A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors (SYLVER) |
Acronym | SYLVER |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Denver | Colorado | 80218 | United States | Details | |
GSK Investigational Site | Augusta | Georgia | 30912 | United States | Details | |
GSK Investigational Site | Detroit | Michigan | 48201 | United States | Details | |
GSK Investigational Site | New York | New York | 10016 | United States | Details | |
GSK Investigational Site | Philadelphia | Pennsylvania | 19104 | United States | Details | |
GSK Investigational Site | Philadelphia | Pennsylvania | 19107 | United States | Details | |
GSK Investigational Site | Melbourne | Victoria | 3000 | Australia | Details | |
GSK Investigational Site | Chiba | 277-8577 | Japan | Details | ||
GSK Investigational Site | Shizuoka | 411-8777 | Japan | Details | ||
GSK Investigational Site | Tokyo | 104-0045 | Japan | Details | ||
GSK Investigational Site | Tokyo | 135-8550 | Japan | Details | ||
GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
GSK Investigational Site | Nijmegen | 6525 GA | Netherlands | Details | ||
GSK Investigational Site | Rotterdam | 3015 GD | Netherlands | Details |